Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH

Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH

Objective: To review follow-up imaging after equivocal bone scans in men with castration resistant prostate cancer (CRPC) and examine the characteristics of equivocal bone scans that are associated with positive follow-up imaging. Methods: We identified 639 men from five Veterans Affairs Hospitals w...

Full description

Saved in:

Bibliographic Details
Main Authors:	Brian T. Hanyok, Mary M. Everist, Lauren E. Howard, Amanda M. De Hoedt, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Christopher L. Amling, Martha K. Terris, Stephen J. Freedland
Format:	Article
Language:	English
Published:	Elsevier 2019-07-01
Series:	Asian Journal of Urology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388219300049
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Radiologically Equivocal Bone Lesions Finally Diagnosed by Bone Scan
by: Mai Amr Elahmadawy, et al.
Published: (2025-05-01)

Equivocal Politics of Carnival
by: Gustavo A. Remedi
Published: (2020-11-01)

Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
by: Himisha Beltran, et al.
Published: (2025-08-01)

Uncertainty in the timing of diversification of flowering plants rests with equivocal interpretation of their fossil record
by: James W. Clark, et al.
Published: (2025-05-01)

Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer
by: Matthew E. Pollard, et al.
Published: (2017-01-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Role of exosomes in castration-resistant prostate cancer
by: Yuan Cao, et al.
Published: (2025-05-01)

Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration
by: Masayoshi Zaitsu, et al.
Published: (2012-01-01)

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024-11-01)

Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
by: Teresa Maria Santos Amaral, et al.
Published: (2012-01-01)

Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
by: Andrew Meyer, et al.
Published: (2012-01-01)

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
by: Rahim Hirani, et al.
Published: (2025-06-01)

Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by Immunohistochemistry
by: Tsai YF, et al.
Published: (2025-03-01)

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer
by: Alexander W Wyatt, et al.
Published: (2015-04-01)

Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer
by: Takuya Koie, et al.
Published: (2020-01-01)

Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer
by: Jesal C. Patel, et al.
Published: (2013-01-01)

THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
by: K. Y. Kanukoev, et al.
Published: (2015-04-01)

New Horizons In The Treatment Of Metastatic Castrate Resistant Prostate Cancer
by: Zein El Amir
Published: (2023-06-01)

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)

Prenylated Chalcones as Anticancer Agents Against Castration-Resistant Prostate Cancer
by: Marcos Morales-Reyna, et al.
Published: (2025-06-01)

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer
by: Belinda Nghiem, et al.
Published: (2016-10-01)

PREVENTION OF COMPLICATIONS IN CASTRATE-REFRACTORY PROSTATE CANCER PATIENTS WITH BONE METASTASES
by: K. M. Nushko, et al.
Published: (2015-10-01)

NASP implication in the androgen receptor associated with castration resistance in prostate cancer
by: Yun Feng, et al.
Published: (2025-07-01)

Utility of pembrolizumab for metastatic castrate resistant prostate cancer with MMR deficiency
by: Brian F. Dinerman, et al.
Published: (2024-11-01)

Long-term ultrasonographic changes of the canine prostate gland after castration
by: Stefano Spada, et al.
Published: (2025-01-01)

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer
by: Marina N. Sharifi, et al.
Published: (2025-08-01)

HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review
by: Goran Bencina, et al.
Published: (2023-06-01)

Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan
by: Takahiro Kimura, et al.
Published: (2025-02-01)

Finite Element Analysis of Dynamic Meshing Characteristic of Skew Bevel Gear with Equivocal Modification
by: Xiaoping Ran, et al.
Published: (2022-05-01)

AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients
by: Todd P. Knutson, et al.
Published: (2024-12-01)

The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer
by: Genta Iwamoto, et al.
Published: (2021-07-01)

ROLE OF NEUREGULINS AND HEPATOCYTE GROWTH FACTOR IN THE DEVELOPMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: L. V. Spirina, et al.
Published: (2016-02-01)

Therapy results of patients with metastatic castration‑resistant prostate cancer. Regional experience
by: P. G. Berezin, et al.
Published: (2023-03-01)

A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer
by: Jones T. Nauseef, et al.
Published: (2025-03-01)

Number of Prescription Medications and Overall Survival in Metastatic Castrate-Resistant Prostate Cancer
by: Carley R. Pickett, et al.
Published: (2024-01-01)

Serious Hypokalemia Associated with Abiraterone Acetate in Patients with Castration-Resistant Prostate Cancer
by: Yutaka Yamamoto, et al.
Published: (2018-01-01)

Expression of MUS81 Mediates the Sensitivity of Castration-Resistant Prostate Cancer to Olaparib
by: Lifeng Gong, et al.
Published: (2022-01-01)

Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors
by: Zixi Wu, et al.
Published: (2025-12-01)

New horizons for treating castration resistant prostate cancer: Bipolar Androgen Therapy
by: Pedro Henrique Isaacsson Velho, et al.
Published: (2018-04-01)

Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features
by: Ameya D. Puranik, et al.
Published: (2019-07-01)